870
Views
0
CrossRef citations to date
0
Altmetric
Research Article

New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies

, ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Article: 2311818 | Received 09 Aug 2023, Accepted 24 Jan 2024, Published online: 15 Mar 2024

References

  • Global cancer report, world health organization. https://www.who.int/en/news-room/fact-sheets/detail/cancer [accessed in June 2023].
  • Khalifa MM, Al-Karmalawy AA, Elkaeed EB, Nafie MS, Tantawy MA, Eissa IH, Mahdy HA. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: Design, synthesis, anti-proliferative, docking, and in vivo studies. J Enzyme Inhib Med Chem. 2022;37(1):299–314.
  • Hammoud MM, Nageeb AS, Morsi MA, Gomaa EA, Elmaaty AA, Al-Karmalawy AA. Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers. New J Chem. 2022;46(23):11422–11436.
  • Gaber AA, Sobhy M, Turky A, Eldehna WM, El-Sebaey SA, El-Metwally SA, El-Naggar AM, Ibrahim IM, Elkaeed EB, Metwaly AM, et al. New [1,2,4]triazolo[4,3-c]quinazolines as intercalative topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies. PLOS One. 2023;18(1):e0274081.
  • Singh I, Luxami V, Paul K. Synthesis of naphthalimide-phenanthro[9,10-d]imidazole derivatives: In vitro evaluation, binding interaction with DNA and topoisomerase inhibition. Bioorg Chem. 2020;96:103631.
  • Zhao M, Yang K, Zhu X, Gao T, Yu W, Liu H, You Z, Liu Z, Qiao X, Song Y. Design, synthesis and biological evaluation of dual topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs. Eur J Med Chem. 2023;252:115303.
  • Swedan HK, Kassab AE, Gedawy EM, Elmeligie SE. Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme. J Enzyme Inhib Med Chem. 2023;38(1):118–137.
  • Deng X, Luo T, Zhang X, Li Y, Xie L, Jiang W, Liu L, Wang Z. Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer. Eur J Med Chem. 2022;237:114376.
  • Skok Ž, Durcik M, Zajec Ž, Gramec Skledar D, Bozovičar K, Pišlar A, Tomašič T, Zega A, Peterlin Mašič L, Kikelj D, et al. ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold. Eur J Med Chem. 2023;249:115116.
  • Xu G, Li Z, Ding Y, Shen Y. Discovery of 1,2-diphenylethene derivatives as human DNA topoisomerase II catalytic inhibitors and antitumor agents. Eur J Med Chem. 2022;243:114706.
  • Swedan HK, Kassab AE, Gedawy EM, Elmeligie SE. Topoisomerase II inhibitors design: Early studies and new perspectives. Bioorg Chem. 2023;136:106548.
  • Singh V, Afshan T, Tyagi P, Varadwaj PK, Sahoo AK. Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics. Int J Biol Macromol. 2023;226:473–484.
  • Kumar M, Kumar D, Raj V. Studies on imidazole and its derivatives with particular emphasis on their chemical/biological applications as bioactive molecules/intermediated to bioactive molecule. Curr Synth and Syst Biol. 2017;05(01):1–10.
  • Zhang H-B, Zhang X-F, Chai L-Q, Tang L-J, Zhang H-S. Zinc(ii) and cadmium(ii) complexes containing imidazole ring: Structural, spectroscopic, antibacterial, DFT calculations and hirshfeld surface analysis. Inorganica Chim Acta. 2020;507:119610.
  • Al-Wahaibi LH, Youssif BGM, Taher ES, Abdelazeem AH, Abdelhamid AA, Marzouk AA. Design, synthesis, biological evaluation, and computational studies of novel tri-aryl imidazole-benzene sulfonamide hybrids as promising selective carbonic anhydrase IX and XII inhibitors. Molecules. 2021;26(16):4718.
  • Yang YQ, Chen H, Liu QS, Sun Y, Gu W. Synthesis and anticancer evaluation of novel 1h-benzo[d]imidazole derivatives of dehydroabietic acid as pI3Kα inhibitors. Bioorg Chem. 2020;100:103845.
  • Alghamdi SS, Suliman RS, Almutairi K, Kahtani K, Aljatli D. Imidazole as a promising medicinal scaffold: Current status and future direction. Drug Des Devel Ther. 2021;15:3289–3312.
  • Al-Harbi RAK, Al-Sharari MAM, El-Sharief MAMS. Synthesis and anticancer evaluation of imidazolidine derivatives: Study the reaction of imidazolidine-iminothione derivatives with amino acids methyl ester. J Taibah Univ for Sci. 2020;14(1):842–848.
  • Sharma P, LaRosa C, Antwi J, Govindarajan R, Werbovetz KA. Imidazoles as potential anticancer agents: An update on recent studies. Molecules. 2021;26(14):4213.
  • Lungu CN, Bratanovici BI, Grigore MM, Antoci V, Mangalagiu II. Hybrid imidazole-pyridine derivatives: An approach to novel anticancer DNA intercalators. Curr Med Chem. 2020;27(1):154–169.
  • Biskupiak JE, Grierson JR, Rasey JS, Martin GV, Krohn KA. Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging. J Med Chem. 1991;34(7):2165–2168.
  • Zaki I, Ramadan HMM, El-Sayed EH, Abd El-Moneim M. Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine-2-thiones as VEGFR-2 enzyme inhibitors. Arch Pharm (Weinheim)). 2020;353(11):e2000121.
  • Aruchamy B, Drago C, Russo V, Pitari GM, Ramani P, Aneesh TP, Benny S, Vishnu VR. Imidazole-pyridine hybrids as potent anti-cancer agents. Eur J Pharm Sci. 2023;180:106323.
  • Sadula A, Gaddhe L. Synthesis, computational studies and biological evaluation of novel acenaphthoquinone-imidazole derivatives as dual inhibitors of HSP90 and topo II in cancer therapy. Results Chem. 2023;5:100796.
  • Singh I, Rani R, Luxami V, Paul K. Synthesis of 5-(4-(1h-phenanthro[9,10-d]imidazol-2-yl)benzylidene)thiazolidine-2,4-dione as promising DNA and serum albumin-binding agents and evaluation of antitumor activity. Eur J Med Chem. 2019;166:267–280.
  • Franchetti P, Marchetti S, Cappellacci L, Yalowitz J, Jayaram H, Goldstein B, Grifantini M. A new c-nucleoside analogue of tiazofurin. Bioorg Med Chem Lett. (1)2001;11:67–69.
  • Cui B, Zheng BL, He K, Zheng QY. Imidazole alkaloids from lepidium meyenii. J Nat Prod. 2003;66(8):1101–1103.
  • El Ashry ESH, Hamid HA, Kassem AA, Shoukry M. Synthesis and reactions of acenaphthenequinones-part-2. The reactions of acenaphthenequinones. Molecules. 2002;7(2):155–188.
  • Ziarani G, Hajiabbasi P, Gholamzadeh P. Cheminform abstract: Development of the acenaphthenequinone reactions. Chem Inform. 2012;43(45).
  • Yavari I, Khajeh Khezri A. Recent advances in the synthesis of hetero- and carbocyclic compounds­ and complexes based on acenaphthylene-1,2-dione. Synthesis. 2018;50(20):3947–3973.
  • Hyatt JL, Wadkins RM, Tsurkan L, Hicks LD, Hatfield MJ, Edwards CC, Ross CR, Cantalupo SA, Crundwell G, Danks MK, et al. Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1. J Med Chem. 2007;50(23):5727–5734.
  • Rodriguez-Argüelles MC, Belicchi Ferrari M, Gasparri Fava G, Pelizzi C, Pelosi G, Albertini R, Bonati A, Dall’Aglio PP, Lunghi P, Pinelli S. Acenaphthenequinone thiosemicarbazone and its transition metal complexes: Synthesis, structure, and biological activity. J Inorg Biochem. 1997;66(1):7–17.
  • Zhang Z, Yang H, Wu G, Li Z, Song T, Li XQ. Probing the difference between BH3 groove of MCL-1 and BCL-2 protein: Implications for dual inhibitors design. Eur J Med Chem. 2011;46(9):3909–3916.
  • Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185–229.
  • Aly AA, Alshammari MB, Ahmad A, A. M. Gomaa H, G. M. Youssif B, Bräse S, A. A. Ibrahim M, Mohamed AH. Design, synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents. Arab J Chem. 2023;16(4):104612.
  • Alshammari MB, Aly AA, Youssif BGM, Bräse S, Ahmad A, Brown AB, Ibrahim MAA, Mohamed AH. Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E. Front Chem. 2022;10:1076383.
  • Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase iiα and induce apoptosis in G1/S phase. J Med Chem. 2011;54(14):5013–5030.
  • Vimala G, Govindaraj J, Haribabu J, Karvembu R, SubbiahPandi A. Crystal structure of (2e)-n-methyl-2-(2-oxo-1,2-di-hydroacenaphthylen-1-ylidene)hydrazinecarbo-thioamide. Acta Crystallogr Sect E Struct Rep Online. 2014;70(Pt 11):415–417.
  • Aly AA, Mohamed NK, Hassan AA, El-Shaieb KM, Makhlouf MM, Bräse S, Nieger M, Brown AB. Functionalized 1,3-thiazolidin-4-ones from 2-oxo-acenaphtho-quinylidene- and [2.2]paracyclophanylidene-thiosemicarbazones. Molecules. 2019;24(17):3069.
  • Ethics committee, faculty of medicine, Alexandria university, member of ICLAS, FWO: 00018699, sn: 0107785 (11/6/2023.
  • Institutional animal care and use committee, Alexandria university, member of ICLAS, SN: 188 (21/6/2023.
  • El-Wakil MH, Khattab SN, El-Yazbi AF, El-Nikhely N, Soffar A, Khalil HH. New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis. Bioorg Chem. 2020;105:104393.
  • El-Yazbi AF, Loppnow GR. 2-aminopurine hairpin probes for the detection of ultraviolet-induced DNA damage. Anal Chim Acta. 2012;726:44–49.
  • El-Yazbi AF, Wong A, Loppnow GR. A luminescent probe of mismatched DNA hybridization: Location and number of mismatches. Anal Chim Acta. 2017;994:92–99.
  • Sabbatini N, Guardigli M, Lehn J-M. Luminescent lanthanide complexes as photochemical supramolecular devices. Coord Chem Rev. 1993;123(1-2):201–228.
  • Valente P, Lincoln SF, Wainwright KP. External coordination of europium(III) prior to its encapsulation within a cyclen-based pendant donor macrocycle. Inorg. Chem. 1998;37(12):2846–2847.
  • El-Yazbi AF, Khalil HA, Belal TS, El-Kimary EI. Inexpensive bioluminescent genosensor for sensitive determination of DNA damage induced by some commonly used sunscreens. Anal Biochem. 2022;651:114700.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. (1-2)1983;65:55–63.
  • Prayong P, Barusrux S, Weerapreeyakul N. Cytotoxic activity screening of some indigenous thai plants. Fitoterapia. 2008;79(7-8):598–601.
  • Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc. 2006;1(3):1458–1461.
  • Zaki I, Abdelhameid MK, El-Deen IM, Abdel Wahab AHA, Ashmawy AM, Mohamed KO. Design, synthesis and screening of 1,2,4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. Eur J Med Chem. 2018;156:563–579.
  • Abdel-Shafy HI, Mansour MSM. A review on polycyclic aromatic hydrocarbons: Source, environmental impact, effect on human health and remediation. Egypt J Pet. 2016;25(1):107–123.
  • Smith J, Neupane R, McAmis W, Singh U, Chatterjee S, Raychoudhury S. Toxicity of polycyclic aromatic hydrocarbons involves nox2 activation. Toxicol Rep. 2019;6:1176–1181.
  • Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, Raghavan SC. Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep. (1)2016;6:24049.
  • Lee JH, Berger JM. Cell cycle-dependent control and roles of DNA Topoisomerase II. Genes (Basel). 2019;10(11):859.
  • https://www.Mybiosource.Com/top2b-human-ELISA-kits/DNA-topoisomerase-2-beta/763112; 2023 [accessed in June 2023].
  • Molecular operating environment (MOE), chemical computing group inc.:Montreal, qc, Canada. http://www.Chemcomp.Com; 2023 [last accessed 20 June 2023].
  • Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model. 2009;49(2):444–460.
  • Daina A, Michielin O, Zoete V. Swissadme: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. (1)2017;7:42717.
  • Daina A, Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem. 2016;11(11):1117–1121.
  • Cheng T, Zhao Y, Li X, Lin F, Xu Y, Zhang X, Li Y, Wang R, Lai L. Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model. 2007;47(6):2140–2148.
  • Szakács G, Váradi A, Ozvegy-Laczka C, Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (adme-tox). Drug Discov Today. 2008;13(9-10):379–393.
  • Farghaly AH., Abdel‐Rahman . Synthesis, reactions and antimicrobial activity of some new indolyl-1,3,4-oxadiazole, triazole and pyrazole derivatives. J Chinese Chemical Soc. (1)2004;51:147–156.
  • Di L. The role of drug metabolizing enzymes in clearance. Expert Opin Drug Metab Toxicol. 2014;10(3):379–393.
  • Hollenberg PF. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev. 2002;34(1–2):17–35.
  • Huang S-M, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, et al. New era in drug interaction evaluation: US food and drug administration update on cyp enzymes, transporters, and the guidance process. J Clin Pharmacol. 2008;48(6):662–670.
  • Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010;53(7):2719–2740.
  • Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615–2623.